Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVR: BULLS AND BEARS! -- Ignore unavailable to you. Want to Upgrade?

To: DAN LITTLE who wrote (5737)	4/30/1998 10:22:00 AM
From: OLD JAKE JUSTUS	Read Replies (1) \| Respond to of 8902

Dan, see what I mean about alibis? I know many, many people that were holding out for $5.00, per share, on ADVR; and these same folks have never sold a share and are still waiting. It will come! That is a pretty good return. Three cents to five dollars, in 12 years, or so! Everybody to their own strategy!

To: DAN LITTLE who wrote (5737)	4/30/1998 11:24:00 AM
From: Richard Phillips	Read Replies (1) \| Respond to of 8902

Dan. Have not had time to read all of the Articles on that URL, but wanted to post an update on what I did find. Most of the information was on what HIV was & how to prevent HIV. They also talked about the diet of people with HIV. (Natural Foods) --- No mention of RETICULOSE or ADVR by name. -- The only thing that I found interesting so far, - Translated most of it. I'm only posting a small part of that Article. --------------------------------- A relatively recent conference sponsored by National Institutes of Health (NIH) was concentrated exclusively in the integrasa of the HIV. The encounter, that it was the first in their/its/your/his gender, achieved to gather scientific several that studied each aspect of the enzyme of the integrasa. Many of the presented investigations were concentrated in how the enzyme achieves their/its/your/his primary objective and the possible approximations to block the integration of the genoma of the HIV. The scientists of the NIH informed about the three-dimensional structure of the active site of the integrasa of the HIV and, therefore, proveyeron a reference framework so that the biochemists could design possible inhibitors of the integrasa. Similar studies of the proteasa of the HIV supplied the means to produce quickly several of the inhibitors of the proteasa currently in use. ------------- There were too many articles, with the same information to scan trough. I will continue reading , watch for more information on that URL. If anything looks good, I will post only that part of the article. O'Pops ><>